The Nobel Prize Laureate Summit is a high profile annual meeting in China that was initiated in 2014 by Nobel Laureate in Physiology/Medicine Sir Richard Roberts, and is hosted by the International Society of Scientific Communications for Nobel Prize Laureates.
2015 Nobel Laureate Summit
Please join us for China’s Most Anticipated Medical Science Event of 2015
At this annual summit, learn directly from some of the world’s leading scientists and physicians who have made dramatic breakthroughs in cancer therapy.
China International Conference Center for Science and Technology
Oncology Progress journal, Peking Union Medical College Press
World Nobel Medical Media Co Ltd
ReLife International Medical Center
Dr. Xishan Hao
Scientific Committee Chair:
Dr. Jack Szostak
Frontiers in Cancer Science
About the Nobel Prize Laureate Summit (NPLS)
The Nobel Prize Laureate Summit is a high profile annual meeting in China that was initiated in 2014 by Nobel Laureate in Physiology/Medicine Sir Richard Roberts, and is hosted by the International Society of Scientific Communications for Nobel Prize Laureates. The vision was of a meeting that would bring some of the world’s most eminent scientists to China not just to meet and foster collaboration with their counterparts there, but also inspire a new generation of young Chinese students and scientists.
Preliminary Summit Program Highlights
The 2015 Nobel Prize Laureate Summit (NPLS) hosted by the Chinese Anti-Cancer Association, Massachusetts General Hospital Cancer Center and the International Society of Scientific Communications for Nobel Prize Laureates (ISSCNL) will take place in Beijing, China (Press Conference) and Tianjin, China (Summit Meeting) from May 8th to May 10, 2015.
NPLS is conceived as a forum for the exchange of ideas and scientific communication amongst the world leading scientists and medical professionals, with the goal of translating learning into action by individuals and public and private institutions.
The 2015 NPLS will focus on the topic ‘Frontiers in Cancer Science’. Topics will include Molecular and Cellular Biology, Cancer Biology, Chemistry in Cancer, Tumorigenesis, Clinical Research and Clinical Trials, Epidemiology, Endocrinology, Targeted Molecular Therapy, Immunology, and Cancer Prevention Studies. This year, the Summit Meeting will include five Nobel Laureates and many of the world’s top cancer research professionals. Young Chinese scientists as well as academy members will have the opportunity to interact with various colleagues and professionals from China and abroad.
NPLS supports the vigorous pursuit of China’s fight against cancer, making it a global effort by establishing new international collaborations between physicians and scientists in industry, academia and government. Efforts include new drug development and research findings but will not be confined to those research areas. Commercial exhibitions regarding tumor-related drugs, new reagents, medical instruments and publications will also be part of the 2015 NPLS.
Jack W. Szostak
2009 Nobel Laureate in Physiology or Medicine, Member of the American National Academy of Sciences. Dr. Jack W. Szostak was awarded the 2009 Nobel Prize for Physiology or Medicine, along with Elizabeth Blackburn and Carol W. Greider, for the discovery of how chromosomes are protected by telomeres.
Craig C. Mello
2006 Nobel Laureate in Physiology or Medicine, Professor of the Program in Molecular Medicine at the University of Massachusetts Medical School. Dr. Craig C. Mello was awarded the 2006 Nobel Prize for Physiology or Medicine, along with Andrew Z. Fire, for their discovery of RNA interference (gene silencing by double-stranded RNA).
Barry J. Marshall
2005 Nobel Laureate in Medicine or Physiology, Member, the American National Academy of Sciences and British Royal Society. Dr. Barry J. Marshall was awarded the 2005 Nobel Prize in Physiology or Medicine for the discovery that stomach ulcers can result from bacteria, and can be cured by antibiotics.
Thomas C. Südhof
2013 Nobel Laureate in Physiology or Medicine, Professor of Molecular and Cellular Physiology at Stanford University School of Medicine Dr. Thomas C. Südhof is well known for his study of synaptic transmission. He was awarded the 2013 Nobel Prize in Physiology or Medicine (with James Rothman and Randy Schekman) for work on vesicle trafficking.
Richard J. Roberts
1993 Nobel Laureate in Physiology or Medicine, Chief Scientific Officer of New England Biolabs. Dr. Richard Roberts was awarded the 1993 Nobel Prize in Physiology or Medicine with Phillip Sharp for the discovery of introns in eukaryotic DNA and the mechanism of gene-splitting.
Daniel A. Haber
Member of the American Academy of Arts & Science, Director of the Massachusetts General Hospital Cancer Center . Dr. Daniel A. Haber’s laboratory interests have focused on the area of cancer genetics, including the etiology of the pediatric kidney cancer Wilms tumor and genetic predisposition to breast cancer.
James P. Allison
Member of the American National Academy of Sciences, Professor and Chair of Immunology and Director of Immunotherapy Platform at M. D. Anderson Cancer Center. Dr. James P. Allison innovative cancer research in the area of immunotherapy led to the successful development of “immune checkpoint therapy,” and the first FDA-approved drug for the treatment of metastatic melanoma.
Brian J. Druker
Member of the American National Academy of Sciences, Director of Oregon Health & Science University (OHSU) Knight Cancer Institute, JELD-WEN Chair of the Leukemia Research. Dr. Brian J. Druker won the Lasker-DeBakey Clinical Medical Research Award and the Meyenburg Cancer Research Prize in 2009 for his influential work in the development of STI571, commonly known as Gleevec, for the treatment of chronic myeloid leukemia (CML).
Carl H. June
Member of the American Academy of Arts & Science, Director of the Translational Research Program at Abramson Cancer Center of University of Pennsylvania. Dr. Carl H. June research interests have focused on lymphocyte biology, with a major translational focus on ex vivo T cell engineering for cancer and HIV cell based therapies.
Steve A. Kay
Member of the American National Academy of Sciences, Dean of Dornsife College of Letters, Arts and Sciences at University of Southern California. Dr. Steve A. Kay is a leader on the genetics of circadian rhythms or the biological clock, and its profound implications for human health as well as for agriculture.
• Government officials from the ministry of health
• Biomedical enterprises and medical equipment manufacturers
• Medical colleges and their faculty and students
• China’s hospital directors, physicians, and medical science researchers
• Medical investment professionals
• Relevant industry managers
For more information about the 2015 Nobel Laureate Summit or to register for the summit, do not hesitate to contact us!